ストックスクリーナーアプリを入手
14.53
5.99%
-0.925
プレマーケット:
14.96
0.43
+2.96%
Unbuzzd Wellness Inc (QNTM) 最新ニュース
Quantum BioPharma Ltd. Clarifies Misinformation Regarding Name Change and RTO Rumors - citybuzz -
Quantum BioPharma Clarifies Name Confusion, Refutes RTO Rumors With Unbuzzd Wellness - Nasdaq
Quantum BioPharma Clarifies It Has Not Changed Its Name | QNTM S - GuruFocus
Quantum BioPharma clarifies misinformation on stock name, RTO rumors - Investing.com
Quantum BioPharma clarifies company has not changed its name - TipRanks
Quantum BioPharma (QNTM) Clarifies Company Name and Transaction Rumors | QNTM Stock News - GuruFocus
Quantum BioPharma Addresses Misinformation and Financial Agreements - TipRanks
Quantum BioPharma Addresses Misinformation Regarding Unbuzzd Wellness and Clarifies Stock Trading Platform Errors - Nasdaq
Quantum BioPharma Clarifies It Has Not Changed Its Name - GlobeNewswire
Quantum BioPharma Resolves Legal Dispute with Former CEO, Secures $2.35 Million Settlement - citybuzz -
What's Going On With Quantum Biopharma Stock Today? - Benzinga
Quantum BioPharma (QNTM) Settles Disputes with Former CEO | QNTM Stock News - GuruFocus
Quantum BioPharma Settles Legal Dispute with Former CEO, Receives $2.35 Million - TipRanks
Quantum BioPharma settles disputes with former CEO - Investing.com
Quantum Biopharma Brief: Says Received US$2.35 Million From a Mutually-Agreed Global Legal Settlement with Dr. Raza Bokhari - marketscreener.com
Quantum BioPharma Receives $2.35 Million USD from a - GlobeNewswire
Quantum BioPharma Ends 4-Year Legal Battle with $2.35M Settlement Payment from Ex-CEO - Stock Titan
Quantum BioPharma appoints MNP for IPO readiness audits By Investing.com - Investing.com South Africa
Unbuzzd Wellness Prepares for Potential IPO with New Auditor Appointment - citybuzz -
Quantum Biopharma Licensee Celly Nutrition Retains Leading Audit - GuruFocus
Quantum BioPharma (QNTM) Engages New Auditor for Potential IPO | - GuruFocus
Quantum BioPharma (QNTM) Engages New Auditor for Potential IPO | QNTM Stock News - GuruFocus
Quantum BioPharma’s Licensee Unbuzzd Wellness Prepares for IPO with Audit Firm Engagement - TipRanks
Quantum BioPharma announces Unbuzzd Wellness hired audit firm - TipRanks
Quantum BioPharma appoints MNP for IPO readiness audits - Investing.com Australia
Quantum BioPharma Ltd. Announces Unbuzzd Wellness Inc. Hires MNP LLP for PCAOB Audits Ahead of Possible IPO and Company Name Change - Nasdaq
Quantum Biopharma Licensee Celly Nutrition Retains Leading Audit Firm MNP LLP to Advance Capital Raise and Go-Public Readiness and Changes Name To Unbuzzd Wellness Inc. - GlobeNewswire
Ex-Coca Cola Exec's Hangover Cure Company Unbuzzd Takes Major Step Toward IPO With Top Audit Firm - Stock Titan
Quantum BioPharma Receives Ethics Committee Approval for Phase 2 Clinical Trial of FSD202 - marketscreener.com
Quantum Group announces subsidiary received approval by HREC in Australia - TipRanks
Quantum BioPharma (QNTM) Gets Green Light for Australian Clinica - GuruFocus
Quantum BioPharma (QNTM) Gets Green Light for Australian Clinical Trial | QNTM Stock News - GuruFocus
Quantum BioPharma Gains Approval for Phase 2 Trial of FSD202 - TipRanks
Quantum BioPharma Receives Ethics Committee Approval for - GlobeNewswire
Quantum BioPharma selects BitGo to securely store its cryptocurrency assets; - MSN
Quantum BioPharma selects BitGo for crypto custody By Investing.com - Investing.com South Africa
Quantum Biopharma Chooses BitGo to Store Cryptocurrency Holdings - marketscreener.com
Quantum BioPharma (QNTM) Partners with BitGo for Crypto Custody - GuruFocus
Quantum BioPharma Partners with BitGo for Crypto Asset Security - TipRanks
Quantum BioPharma selects BitGo for crypto custody - Investing.com
Quantum BioPharma Ltd. Partners with BitGo Trust for Secure Management of Cryptocurrency Assets - Nasdaq
Quantum BioPharma Partners with BitGo to Securely Store its Crypto Currency Assets - GlobeNewswire
Cannabis Stocks To Follow Today – May 19th - Defense World
Quantum BioPharma advances MS drug towards Phase 2 trial By Investing.com - Investing.com South Africa
Quantum Biopharma buys additional $1 million of Bitcoin, other cryptocurrencies - MSN
Quantum BioPharma advances MS drug towards Phase 2 trial - Investing.com Australia
Quantum Biopharma Announces Signing of an Agreement with a - GlobeNewswire
Endeavour Moves To Adjust Debt, Quantum Boosts Bitcoin Holdings - Finimize
Quantum BioPharma (QNTM) Advances MS Treatment with New IND Appl - GuruFocus
Quantum Biopharma Seals Deal With Contract Research Organization for Lucid-MS Application - marketscreener.com
Quantum BioPharma (QNTM) Advances MS Treatment with New IND Application | QNTM Stock News - GuruFocus
Quantum BioPharma Advances MS Treatment with New IND Agreement - TipRanks
Quantum BioPharma Ltd. Advances MS Treatment Development with IND Application Agreement for Lucid-21-302 - Nasdaq
Quantum Biopharma Brief: To Prepare an IND (Investigational New Drug) Application Package for Lucid-21-302 (Lucid-MS), A First-In-Class Treatment for Multiple Sclerosis - marketscreener.com
Quantum Biopharma Brief: Announcing Signing of an Agreement with a Global Pharmaceutical Contract Research Organization - marketscreener.com
Quantum Biopharma Announces Signing of an Agreement with a Global Pharmaceutical Contract Research Organization to Prepare an IND (Investigational New Drug) Application Package for Lucid-21-302 (Lucid-MS), A First-In-Class Treatment for Multiple S - GlobeNewswire
Revolutionary MS Drug Lucid-21-302 Takes Major Step Toward Clinical Trials with Unique Neuroprotective Approach - Stock Titan
Quantum BioPharma Stock Pops 20%, Retail Bullish Sentiment Builds After $1M Crypto Holdings Boost By Stocktwits - Investing.com India
MT Newswires Canada Stocks To Watch: Endeavour Mining; Quantum BioPharma; XORTX Therapeutics - marketscreener.com
1.38%
0.61%
大文字化:
|
ボリューム (24 時間):